Cetuximab Completed Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00728663Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer